WallStreetZenWallStreetZen

NASDAQ: KZR
Kezar Life Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for KZR

Based on 2 analysts offering 12 month price targets for Kezar Life Sciences Inc.
Min Forecast
$2.00+144.8%
Avg Forecast
$11.00+1,246.39%
Max Forecast
$20.00+2,347.98%

Should I buy or sell KZR stock?

Based on 2 analysts offering ratings for Kezar Life Sciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KZR stock forecasts and price targets.

KZR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is KZR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is KZR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

KZR revenue forecast

What is KZR's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$14.0M+100%
Avg 2 year Forecast
$20.0M+185.71%
Avg 3 year Forecast
$9.3M+32.43%
KZR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KZR revenue growth forecast

How is KZR forecast to perform vs Biotechnology companies and vs the US market?
Company
47.18%
Industry
38.32%
Market
10.27%
KZR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KZR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KZR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KZR$0.82$11.00+1,246.39%Buy
ALGS$0.79N/AN/A
CKPT$1.67$19.00+1,037.72%Strong Buy
RPHM$1.77$1.43-19.04%Hold
IKNA$1.24$9.50+666.13%Buy

Kezar Life Sciences Stock Forecast FAQ

Is Kezar Life Sciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: KZR) stock is to Buy KZR stock.

Out of 2 analysts, 0 (0%) are recommending KZR as a Strong Buy, 1 (50%) are recommending KZR as a Buy, 1 (50%) are recommending KZR as a Hold, 0 (0%) are recommending KZR as a Sell, and 0 (0%) are recommending KZR as a Strong Sell.

If you're new to stock investing, here's how to buy Kezar Life Sciences stock.

What is KZR's revenue growth forecast for 2024-2027?

(NASDAQ: KZR) Kezar Life Sciences's forecast annual revenue growth rate of 47.18% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Kezar Life Sciences's revenue in 2024 is $7,000,000.On average, 1 Wall Street analysts forecast KZR's revenue for 2024 to be $1,019,219,026, with the lowest KZR revenue forecast at $1,019,219,026, and the highest KZR revenue forecast at $1,019,219,026. On average, 1 Wall Street analysts forecast KZR's revenue for 2025 to be $1,456,027,180, with the lowest KZR revenue forecast at $1,456,027,180, and the highest KZR revenue forecast at $1,456,027,180.

In 2027, KZR is forecast to generate $674,868,598 in revenue, with the lowest revenue forecast at $674,868,598 and the highest revenue forecast at $674,868,598.

What is KZR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KZR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is KZR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year KZR price target, the average KZR price target is $11.00, with the highest KZR stock price forecast at $20.00 and the lowest KZR stock price forecast at $2.00.

On average, Wall Street analysts predict that Kezar Life Sciences's share price could reach $11.00 by Mar 15, 2025. The average Kezar Life Sciences stock price prediction forecasts a potential upside of 1,246.39% from the current KZR share price of $0.82.

What is KZR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KZR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.